Neuronal nitric oxide synthase signaling within cardiac myocytes targets phospholamban

American Journal of Physiology - Cell Physiology

Volumn 294, Issue 6, 2008, Pages

  Wang, Honglan ^a   Kohr, Mark J ^a   Traynham, Christopher J ^a   Wheeler, Debra G ^a   Janssen, Paul M L ^a   Ziolo, Mark T ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Force frequency response; NOS1; Peroxynitrite

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM ION; GUANYLATE CYCLASE INHIBITOR; ISOPRENALINE; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PEROXYNITRITE; PHOSPHOLAMBAN; S METHYLTHIOCITRULLINE; 5,10,15,20 TETRAKIS(4 SULFONATOPHENYL)PORPHYRINATO IRON(III) CHLORIDE; 5,10,15,20-TETRAKIS(4-SULFONATOPHENYL)PORPHYRINATO IRON(III) CHLORIDE; CALCIUM BINDING PROTEIN; CITRULLINE; DRUG DERIVATIVE; ENZYME INHIBITOR; METALLOPORPHYRIN; NOS1 PROTEIN, MOUSE; PEROXYNITROUS ACID; S-METHYLTHIOCITRULLINE; THIOUREA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXCITATION CONTRACTION COUPLING; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE WALL; KNOCKOUT MOUSE; MOUSE; MUSCLE FORCE; NONHUMAN; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WILD TYPE; ANIMAL; C57BL MOUSE; CALCIUM SIGNALING; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETICS; HEART CONTRACTION; METABOLISM; MOUSE MUTANT; PHOSPHORYLATION; TIME;

MUS;

ADRENERGIC BETA-AGONISTS; ANIMALS; CALCIUM SIGNALING; CALCIUM-BINDING PROTEINS; CITRULLINE; ENZYME INHIBITORS; ISOPROTERENOL; METALLOPORPHYRINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; NITRIC OXIDE SYNTHASE TYPE I; PEROXYNITROUS ACID; PHOSPHORYLATION; SARCOPLASMIC RETICULUM; THIOUREA; TIME FACTORS;

EID: 47249116239     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00367.2007     Document Type: Article

References (41)

1. Ashley EA, Sears CE, Bryant SM, Watkins HC, Casadei B. Cardiac nitric oxide synthase 1 regulates basal and beta-adrenergic contractility in murine ventricular myocytes. Circulation 105: 3011-3016, 2002.
2. Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, Hobai IA, Lemmon CA, Burnett AL, O'Rourke B, Rodriguez ER, Huang PL, Lima JA, Berkowitz DE, Hare JM. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416: 337-339, 2002.
3. Bassani JW, Yuan W, Bers DM. Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes. Am J Physiol Cell Physiol 268: C1313-C1319, 1995.
4. Bers DM. Cardiac excitation-contraction coupling. Nature 415: 198-205, 2002.
5. Bers DM. Excitation-Contraction Coupling and Cardiac Contractile Force. Dordrecht, The Netherlands: Kluwer Academic, 2001.
6. Bers DM, Ziolo MT. When is cAMP not cAMP? Effects of compartmentalization. Circ Res 89: 373-375, 2001.
7. Carr AN, Schmidt AG, Suzuki Y, del Monte F, Sato Y, Lanner C, Breeden K, Jing SL, Allen PB, Greengard P, Yatani A, Hoit BD, Grupp IL, Hajjar RJ, DePaoli-Roach AA, Kranias EG. Type 1 phosphatase, a negative regulator of cardiac function. Mol Cell Biol 22: 4124-4135, 2002.
8. Chu G, Ferguson DG, Edes I, Kiss E, Sato Y, Kranias EG. Phospholamban ablation and compensatory responses in the mammalian heart. Ann NY Acad Sci 853: 49-62, 1998.
9. Chu G, Lester JW, Young KB, Luo W, Zhai J, Kranias EG. A single site (Ser16) phosphorylation in phospholamban is sufficient in mediating its maximal cardiac responses to beta-agonists. J Biol Chem 275: 38938-38943, 2000.
10. Delgado-Esteban M, Martin-Zanca D, Andres-Martin L, Almeida A, Bolanos JP. Inhibition of PTEN by peroxynitrite activates the phosphoinositide-3- kinase/Akt neuroprotective signaling pathway. J Neurochem 102: 194-205, 2007.
11. First EA, Taylor SS. Selective modification of the catalytic subunit of cAMP-dependent protein kinase with sulfhydryl-specific fluorescent probes. Biochemistry 28: 3598-3605, 1989.
12. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol Pharmacol 48: 184-188, 1995.
13. Gergs U, Boknik P, Buchwalow I, Fabritz L, Matus M, Justus I, Hanske G, Schmitz W, Neumann J. Overexpression of the catalytic subunit of protein phosphatase 2A impairs cardiac function. J Biol Chem 279: 40827-40834, 2004.
14. Gonzalez DR, Beigi F, Treuer AV, Hare JM. Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes. Proc Natl Acad Sci USA 104: 20612-20617, 2007.
15. Hiranandani N, Bupha-Intr T, Janssen PM. SERCA overexpression reduces hydroxyl radical injury in murine myocardium. Am J Physiol Heart Circ Physiol 291: H3130-H3135, 2006.
16. 2+ current in cardiac cells. Am J Physiol Heart Circ Physiol 268: H916-H920, 1995.
17. Janssen PM, Hunter WC. Force, not sarcomere length, correlates with prolongation of isosarcometric contraction. Am J Physiol Heart Circ Physiol 269: H676-H685, 1995.
18. Janssen PM, Periasamy M. Determinants of frequency-dependent contraction and relaxation of mammalian myocardium. J Mol Cell Cardiol 43: 523-531, 2007.
19. Khan SA, Lee K, Minhas KM, Gonzalez DR, Raju SV, Tejani AD, Li D, Berkowitz DE, Hare JM. Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling. Proc Natl Acad Sci USA 101: 15944-15948, 2004.
20. Khan SA, Skaf MW, Harrison RW, Lee K, Minhas KM, Kumar A, Fradley M, Shoukas AA, Berkowitz DE, Hare JM. Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases. Circ Res 92: 1322-1329, 2003.
21. Kinugawa S, Huang H, Wang Z, Kaminski PM, Wolin MS, Hintze TH. A defect of neuronal nitric oxide synthase increases xanthine oxidase-derived superoxide anion and attenuates the control of myocardial oxygen consumption by nitric oxide derived from endothelial nitric oxide synthase. Circ Res 96: 355-362, 2005.
22. Kohr MJ, Wang H, Wheeler DG, Velayutham M, Zweier JL, Ziolo MT. Biphasic effect of SIN-1 is reliant upon cardiomyocyte contractile state. Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2008.03.019.
23. Koss KL, Grupp IL, Kranias EG. The relative phospholamban and SERCA2 ratio: a critical determinant of myocardial contractility. Basic Res Cardiol 92, Suppl 1: 17-24, 1997.
24. Koss KL, Kranias EG. Phospholamban: a prominent regulator of myocardial contractility. Circ Res 79: 1059-1063, 1996.
25. MacLennan DH, Kranias EG. Phospholamban: a crucial regulator of cardiac contractility. Nat Rev Mol Cell Biol 4: 566-577, 2003.
26. Martin SR, Emanuel K, Sears CE, Zhang YH, Casadei B. Are myocardial eNOS and nNOS involved in the beta-adrenergic and muscarinic regulation of inotropy? A systematic investigation. Cardiovasc Res 70: 97-106, 2006.
27. Misko TP, Highkin MK, Veenhuizen AW, Manning PT, Stern MK, Currie MG, Salvemini D. Characterization of the cytoprotective action of peroxynitrite decomposition catalysts. J Biol Chem 273: 15646-15653, 1998.
28. Mulieri LA, Hasenfuss G, Ittleman F, Blanchard EM, Alpert NR. Protection of human left ventricular myocardium from cutting injury with 2,3-butanedione monoxime. Circ Res 65: 1441-1449, 1989.
29. Narayanan K, Griffith OW. Synthesis of L-thiocitrulline, L-homothiocitrulline, and S-methyl-L-thiocitrulline: a new class of potent nitric oxide synthase inhibitors. J Med Chem 37: 885-887, 1994.
30. Sears CE, Bryant SM, Ashley EA, Lygate CA, Rakovic S, Wallis HL, Neubauer S, Terrar DA, Casadei B. Cardiac neuronal nitric oxide synthase isoform regulates myocardial contraction and calcium handling. Circ Res 92: e52-e59, 2003.
31. Shannon TR, Ginsburg KS, Bers DM. Potentiation of fractional sarcoplasmic reticulum calcium release by total and free intra-sarcoplasmic reticulum calcium concentration. Biophys J 78: 334-343, 2000.
32. Sommer D, Coleman S, Swanson SA, Stemmer PM. Differential susceptibilities of serine/threonine phosphatases to oxidative and nitrosative stress. Arch Biochem Biophys 404: 271-278, 2002.
33. Stull LB, Leppo MK, Marban E, Janssen PM. Physiological determinants of contractile force generation and calcium handling in mouse myocardium. J Mol Cell Cardiol 34: 1367-1376, 2002.
34. Trafford AW, Diaz ME, Eisner DA. A novel, rapid and reversible method to measure Ca buffering and time-course of total sarcoplasmic reticulum Ca content in cardiac ventricular myocytes. Pflügers Arch 437: 501-503, 1999.
35. Vila-Petroff MG, Younes A, Egan J, Lakatta EG, Sollott SJ. Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ Res 84: 1020-1031, 1999.
36. 2+ current. Am J Physiol Heart Circ Physiol 294: H1473-H1480, 2008.
37. Xu KY, Huso DL, Dawson TM, Bredt DS, Becker LC. Nitric oxide synthase in cardiac sarcoplasmic reticulum. Proc Natl Acad Sci USA 96: 657-662, 1999.
38. Zhang YH, Zhang MH, Sears CE, Emanuel K, Redwood C, El-Armouche A, Kranias EG, Casadei B. Reduced phospholamban phosphorylation is associated with impaired relaxation in left ventricular myocytes from neuronal NO synthase-deficient mice. Circ Res 102: 242-249, 2008.
39. Zhou L, Burnett AL, Huang PL, Becker LC, Kuppusamy P, Kass DA, Kevin Donahue J, Proud D, Sham JS, Dawson TM, Xu KY. Lack of nitric oxide synthase depresses ion transporting enzyme function in cardiac muscle. Biochem Biophys Res Commun 294: 1030-1035, 2002.
40. Ziolo MT. The fork in the nitric oxide road: cyclic GMP or nitrosylation? Nitric Oxide 18: 153-156, 2008.
41. Ziolo MT, Bers DM. The real estate of NOS signaling: location, location, location. Circ Res 92: 1279-1281, 2003.